Photo taken from Maxwell Lloyd/X
Aug 27, 2024, 17:21
Review of precision therapeutics and emerging strategies in HR+ MBC
Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X:
“Congratulations to Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander for recently published review of precision therapeutics and emerging strategies in HR+ MBC (metastatic breast cancer) in Nature Reviews Clinical Oncology.”
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
Authors: Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander.
Source: Michelle DeMeo/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 24, 2025, 12:50
Apr 24, 2025, 12:33
Apr 24, 2025, 12:10
Apr 24, 2025, 11:59
Apr 24, 2025, 11:48
Apr 24, 2025, 11:31